Objective Treatment response assessment in high-grade gliomas uses contrast enhanced
T1-weighted MRI, but is unreliable. Novel advanced MRI techniques have been studied, but …

Background. Distinction between tumor and treatment related changes is crucial for clinical
management of patients with high-grade gliomas. Our purpose was to evaluate whether …

Objective Summarize evidence for use of advanced MRI techniques as monitoring
biomarkers in the clinic, and highlight the latest bench-to-bedside developments. Methods …

In recent years, the development of advanced magnetic resonance imaging (MRI)
technology and machine learning (ML) have created new tools for evaluating treatment …

OBJECTIVE. The purpose of this article is to address radiation necrosis, pseudoprogression,
and pseudoresponse relative to high-grade gliomas and evaluate the role of conventional …

Currently, the most widely used criteria for assessing response to therapy in high-grade
gliomas are based on two-dimensional tumor measurements on computed tomography (CT) …

Abstract Objectives At a European Society of Neuroradiology (ESNR) Annual Meeting 2015
workshop, commonalities in practice, current controversies and technical hurdles in glioma …

Background Gliomas are the most common primary brain tumour. They are graded using the
WHO classification system, with Grade II‐IV astrocytomas, oligodendrogliomas and …

Magnetic resonance imaging is integral to the care of patients with high-grade gliomas.
Anatomic detail can be acquired with conventional structural imaging, but newer …

Purpose To evaluate the feasibility of a standardized protocol for acquisition and analysis of
dynamic contrast material–enhanced (DCE) and dynamic susceptibility contrast (DSC) …